期刊文献+

新疆地区血液培养病原菌的分布及耐药情况分析

Pathogen distribution charaterstics and drug resistance of blood culture in Xinjiang
下载PDF
导出
摘要 目的了解新疆地区血液感染的主要病原菌及耐药情况。方法 4 534例血液标本采用BACT-ALERT 3D全自动血培养仪进行细菌培养,细菌培养阳性标本采用梅里埃公司的Vitek-TWO系统行菌种鉴定和药敏试验。结果 4 534例血液细菌培养标本中,离出病原菌359株株,阳性率为7.92%,其中革兰阳性菌占53.5%,革兰阴性菌占43.4%,真菌占3.1%。61.9%的金黄色葡萄球菌耐苯唑西林,产ESBLs的大肠埃希菌为60%,产ESBLs的肺炎克雷伯菌为44.4%,未见耐万古霉素的革兰阳性菌。结论新疆地区引起血液感染的主要病原菌以革兰阳性菌为主,耐药菌株广泛出现,及时了解血培养结果,选用敏感药物针对性用药,可有效提高菌血症的治愈率。 Objective To explore the pathogen distribution charaterstics and drug resistance of blood culture in Xinjiang. Meth- ods BACT-ALERT 3D automated blood culture system was used to cuture the 4 534 blood samples,the Vitek-TWO BioMerieux system were used in the identification and susceptibility testing of positive samples species. Results A total of 359 strains were iso- lated from 4 534 blood samples, the positive rate of 7.92 %. Gram-positive cocci accounted for 53.5 %, gram-negative bacteria ac- counted for 43.4 %, fungi accounted for 3.1%. 61.9 % strains was methicillin-resistant. Escherichia cull and Klebsiella β-super-lactamases were 60 % and 44.4 % respectively, no vancomycin-resistant mold elements of the gram-positive cocci was found. Conclusion The main hospital pathogens causing blood culture infections is gram-positive bacteria, the drug resistant bacteria is still wide- spread,keeping abreast of the blood culture results,choosing sensitive drugs could improve the cure rate of bacteremia.
出处 《国际检验医学杂志》 CAS 2015年第2期159-160,162,共3页 International Journal of Laboratory Medicine
基金 新疆维吾尔自治区病原生物学重点学科项目(2013ZRQN35)
关键词 血液培养 病原菌的分布 耐药性 blood culture pathogen distribution drug resistance
  • 相关文献

参考文献7

二级参考文献27

  • 1周颖杰,李光辉.美国感染病学会念珠菌病治疗指南[J].中国感染与化疗杂志,2006,6(3):203-208. 被引量:5
  • 2Clinical and Laboratory Standards. M100-S20 Performance standards for antimicrobial Susceptibility testing~ twentieth informational supplement [S]. USA: CLSI, 2010.
  • 3唐培,刘彤,李金,赵娜,胡志东,王鹏志.2004—2006年医院外科感染常见细菌构成及耐药情况分析[J].天津医药,2007,35(8):584-586. 被引量:10
  • 4Clark TA,Hajjeh RA.Recent trends in the epidemiology of invasive mycoses[J].Curr Opin Infect Dis,2002,15(6):569-574.
  • 5Pfaller MA,Pappas PG,Wingard JR.Invasive fungal pathogens:current epidemiological trends[J].Clin Infect Dis,2006,43:S3-S14.
  • 6Wisplinghoff H,Bischoff T,Tallent SM,et al.Nosocomial bloodstream infections in US hospitals:analysis of 24,179 cases from a prospective nationwide surveillance study[J].Clin Infect Dis,2004,39(3):309-317.
  • 7Kontoyiannis DP,Bodey GP.Invasive aspergillosis in 2002:an update[J].Eur J Clin Microbiol Infect Dis,2002,21(3):161-172.
  • 8Alexander BD,Pfaller MA.Contemporary tools for the diagnosis and management of invasive mycoses[J].Clin Infect Dis,2006,43:S15-S27.
  • 9Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cacer and hematopoietic stem cell transplants:an international consensus[J].Clin infect Dis,2002,34(1):7-14.
  • 10Pappas PG,Rex JH,Sobel JD,et al.Guidelines for treatment of candidiasis[J].Clin Infect Dis,2004,38(2):161-189

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部